Chlorphenamine/codeine

Drug Profile

Chlorphenamine/codeine

Alternative Names: Chlorpheniramine/codeine; Codeine/chlorpheniramine; LPCN 1084; Rinotuss12; Tuxarin

Latest Information Update: 05 Sep 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Lipocine
  • Developer Spriaso
  • Class Antitussives; Morphinans; Opioid analgesics; Sedating antihistamines
  • Mechanism of Action Histamine H1 receptor antagonists; Opioid mu receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Registered Common cold; Cough

Most Recent Events

  • 05 Sep 2017 Chlorphenamine/codeine is still registered for Cough and Common cold in USA (PO) (Spriaso pipeline, September 2017)
  • 22 Jun 2015 Registered for Common cold in USA (PO)
  • 22 Jun 2015 Registered for Cough in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top